MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine

N/A

Report date: 2023/11/21 20:03:29

Base Information

Drug NameMAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine

Drug Alias NameMER-4101

ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNew ZealandAustralia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesMercia Pharma

China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc

Inactive CompaniesNova Immunotherapeutics Ltd

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A